Furosemide vs torsemide

Cisplatin & Radiation Treatment (My Experience)

2024.05.14 18:40 thepurlshq Cisplatin & Radiation Treatment (My Experience)

Update post on my progress and protocols for my treatment with side effects and how I managed it all.
Now that I'm done with treatment, I hope that this can help others who may be starting the same journey and have questions. I attribute my easy time to the premeds and my mental willpower. I focus on the positives and silver linings over the negatives. You can only control one thing -- your reactions. The rest requires you to practice acceptance.
Diagnosis: Stage 2 Endocervical Adenocarcinoma Gastric Type with LVSI
Treatment Plan: Surgery (cervix, uterus, and ovaries) followed by concurrent Chemo with Radiation with a PET Scan scheduled 2 months after treatment to determine if NED or more treatment is required.
I was scheduled for 6 chemo cycles, once a week, and 28 radiation beam therapies. Chemo happened on Monday and Radiation was Monday through Friday. I had to skip Cycle 3 on Chemo only because I was hospitalized with Norovirus and my counts were too low. I still did radiation those days.
Chemo Protocol in order of meds:
  1. Magnesium Sulfate + Potassium Chloride. Cisplatin strips this from your body, supplements.
  2. Emend (Fosaprepitant) - antiemetic. I had to get a port for this, it burned my arm vein and I had to use other arm for Chemo, no fun.
  3. Aloxi (Palonosetron) - antiemetic.
  4. Decadron (Dexamethasone) - steroid. It burns in your nether region, if it burns too much, ask them to push it slower.
  5. Lasix (Furosemide) - diuretic. Cisplatin is hard on kidneys, this is to help purge the chemo faster. Be close to a bathroom and ask nurse if you can just unplug your IV pole and go to bathroom freely vs. pushing call button -- its easier.
  6. Cisplatin (Platinol) 70mg (my dose). Didn't make me feel any different than the other infusions.
Plan for at least 5 hours for the above. I started at 7:30am and ended between 12 and 12:30pm.
Cisplatin Symptoms: This is going to vary person to person and you may get different premeds than me.
Pelvic Radiation Symptoms: This is going to be different based on what areas are treated. My bladder, vagina, and pelvic nodes were heavily treated. Be sure you understand the side effects before you start treatment - so you can be on top of everything. Below is my experience and I had a fairly easy time of it.
Nurses are your best friend. Having cancer and going through treatment sucks, but the nurses are there for you and my experience was all-inclusive resort service. Take advantage of the snacks (yes they have ice cream) when you're getting chemo. Don't be shy about asking them about your meds, they did a good job explaining this to me, but I still had questions now and again. It takes a special person to be an oncology nurse and you feel it. It never felt fake or like they were putting on a show/smile just for me. They truly cared. I never want to see them again either way :)
Edited to add: get a port. You will not regret it. I plan on keeping mine for a year after NED, which will require a monthly flush. It makes things so much easier, especially if you have to be hospitalized. I didn't need the numbing cream, it hurts less than the arm pokes for labs and infusions. I asked for mine before chemo and doctor didn't think it was necessary. First treatment proved it was - I had three IV's that day and I'm still suffering from the Emend infusion (not the chemo surprisingly) on my arm. Yes, its surgery but its easy. I had it in place before my 2nd chemo and it was lifechanging. I'd keep it for life it wasn't for the monthly flushes lol, my arm veins were crap to start and the more they are poked the worse they get.
submitted by thepurlshq to CervicalCancer [link] [comments]


2024.04.19 21:07 ninasinparis I failed my NCLEX at 95 questions, could the quick results have been a mistake? Or failed due to a suspicion of cheating?

Hi y’all, I took my NCLEX 2 days ago and it stopped me at 95 questions. I felt good about myself cause I felt like I knew most of the questions….until now. My quick result said I failed but how possibly? I do not want to believe I failed so hard the computer had to stop me and not let me go up to 150 questions. Could the quick result be wrong? I did write non math related stuff on the whiteboard they gave me but I didn’t write direct questions. I wrote down key words to help jog my memory. For example if I was asked what position to put a patient in I would draw stick figures in those positions to make sure I wasn’t crazy. Or if it was asking about non common pharm I would write down medication with the same ending. Example Torsemide and Furosemide. Writing that down would help me figure out the medication. And I did not write down anything during the tutorial for it to be considered brain dumping. But could I have failed due to a suspicion of cheating? I will not take any chances next time and write ANYTHING down but I’m so distraught 😭😭😭😭😭
submitted by ninasinparis to NCLEX [link] [comments]


2024.04.17 16:03 arose123 4 year old Doberman heart failure - Medicine Check

* Species: Dog
* Age: 4 years
*Sex/Neuter status: Female/Spay
* Breed: Doberman
* Body weight: 36.6 kg
* History:
Talia is a 4 Yrs. 2 Mos. year old, Spayed Female Doberman who was presented to [LOCATION] for chronic diarrhea. Per owner Talia's symptoms first started in mid-October. Since coming through the ER she has not been doing well. She had a very mucoid stool after ER, which was initially improved on the probiotic. Similarly, the owner started prednisone about 11/6 due to concern of pain and not eating. By day 5 the stool was formed and she was playing, had normal mobility, eating and appeared well.Since reducing the prednisone to SID, she has had varying consistencies of stool from liguid to soft somewhat formed. When stools have less consistency the amount seems smaller and she is going about 2x daily, though increased attempts are noted when outside. When her stools are normal she was going about 2x daily. Similarly, since being on the lower dose of steroids her appetite is poor. She ate some treats yesterday, but mostly has not eaten for 2 days per owner. Various enticements have been offered including chicken,tuna, salami which she haslike though variably. Talia was seen by BP SF Urgent Care 9/1/23 where ulcerated bleeding interdigital cysts on both forelimbs, focal ulcerative lesion on the ventral rostral muzzle on exam and had presented for these lesions as well as worsening pruritus. Cefpodoxime and Cytopoint were prescribed. Skin biopsies were declined.
She was then seen byBP SF ER 10/24/23 for diarrhea, lethargy, anorexia. She recently was placed on an NSAID for hind limb pain. Temperature was 103.8, prescapular LN were enlarged and firm (FNA was fat), tense abdomen, generalized stiffness with neck pain, hooded vulva, subluxation of R hip on extension were noted. CBC noted inflammatory leukogram (WBC 22.35, Neut 19.31, mono 1.6), PIt 316K. Chemistry was normalthough glob high normal 4.4 (high 4.5) (alb 3, creat 0.7, choles 184, gluc 128). 4DX negative. In house cortisolwas 6.6. US was normal. B12 was low normal 420, Folate low 4.9 (7.7-24.4), TLI low normal (5-35), PSL low 18. She was positive for roundworm antigens, Giardia PCR, C. perf alpha toxin P C with high level genes. Her fever resolved after started Unasyn and her hypertension and pain (especially hind limbs) were controlled with analgesia. She was discharge on Clavamox, Entyce, Cerenia, Gabapentin.
He was seen 10/26/23 by BP SF Neurology where lymphadenopathy was again noted along with temp 103.2. Discomfort on mid thoracic spine was noted along with hesitance to lay and get up. Congenital spinal malformation was noted onthoracic radiographs with I D space narrowing in thorax, mid to caudal lumbar spaces, L3-L4 notable narrowed with irregular end plate lucency and sclerotic irregular spondylosis deformans. Panacur, gaba, methocarbamol, clavamox was prescribed. Joints taps returned as a predominance of mononuclear cells with increased erythrocytes ni the Lstifle (suspect contamination) with no cytologic abnormalities ni the Lcarpus and tarsus. tI was thought that DISH and/or IDD and/or discospondylitis and/or nerve root entrapment was leadingto her signs. She was then seen byDogWood 11/4/23 at which time Enrofloxacin was prescribed for possible discospondylitis along with amantadine as no improvement was noted on the abovetherapy. Her tempt h e n was 102.9 and localized T3-L3. Steroids were reserved.
Talia has been treated with i/d, fortiflora, Imodium, metronidazole for diarrhea inthe past (2020). In 2020 she had a few episodes of seeming high, panting, not wanting to use her back legs though conscious. She was seen by ER for this and was normal on presentation and drug screen negative. CBC noted mild eosinophilia 1.44 though CBC and chem was otherwise normal. She was treated with doxycycline for presumed kennel cough in April 2021.
Historical urinary incontinence, managed on Prion; anxiety, managed with fluoxetine and trazodone; hind limb pain, managed with recent Deramaxx
LEADS TO NOW: Talia was back to norm and on her meditations - Owner rushed Talia to the emergency vet on 4/10/24 because she wasn't breathing normally.
Here is the dignosis: Congestive heart failure- resolved Left ventricular systolic dysfunction - atypical dilated cardiomyopathy vs secondary to systemic disease (i.e. enteropathy ) Historical diskospondylitis, under management with BluePearl Farmington • T9-10 discospondylitis. Historical urinary incontinence, managed with Proin Historic chronic enteropathy- low folate, low normal B12
* Clinical signs: difficulty breathing (for the latest diagnosis)
* Duration: ~1.5 days
* Your general location: Michigan, USA
* Links to any test results, X-rays, vet reports etc. that you have: https://imgur.com/a/l1cT84I

Previous Medication:
Gabapentin 300mg BID, Proin 74mg BID, Probiotic SID, Prednisone 10mg EOD, Fluoxetine 60mg SID, Amantadine, Enrofloxacin 300mg SID
New Added Medication:
Furosemide 80mg tablets- give 1 tablet by mouth every 12 hours. Please ensure access to water at all times.
Pimobendan 10mg tablets -please give 1 tablet by mouth every 12 hours. Please continue her other medications as previously prescribed: Gabapentin 300mg BID, Proin 74mg BID, Probiotic SID, Prednisone 10mg EOD, Fluoxetine 60mg SID, Amantadine, Enrofloxacin 300mg SID

Question: Is there anything in the previous medication combination that could have caused heart failure? Any concerns of these medications going together? The vets keep telling me to go to one person to other to get clarity and I'm getting concerned in the level of knowledge.
submitted by arose123 to AskVet [link] [comments]


2024.03.05 20:41 Mindless_Friend8235 Why do ER vets stress euthanasia with long-term managed conditions so much?

One of our dogs (11.5 years) has advanced mitral valve disease, and has been in the excellent care of a Board Certified Cardiologist for several years. (USA)
In December, our dog had a crisis of Congestive Heart Failure. We spoke to our cardiologist who considered this routine, expected, and not a big deal in their long-term care. They advised a few days of IV Lasix therapy and went to their recommended ER. The criticalist kept suggesting and advocating euthanasia during intake, noting the cost and prognosis. We kept replying our dog's condition has been managed long-term by a board certified cardiologist, we have insurance, and we have been prepared they may have several ER trips in their final years. The criticalist replied we should consider euthanasia for cost, because they will not accept insurance and require a large deposit. We insisted on treatment. An hour later we are introduced to their head of cardiology, who looked over the case and expected a speedy and routine recovery. 36 hours later, our dog is home on a new regimen of medicine and is thriving. After a bit of analysis and adjusting the dose, our cardiologist realized there was evidence of a furosemide tolerance developing for several months, and we switched to torsemide.
In February, the same dog spiraled into dehydration and acute kidney failure after a bout of diarrhea (two bowel movements within 8 hours) after a positive cardio recheck that day. Our normal vet and cardiologist coordinated treatment plans to balance the concerns for hydration/kidneys with cardiac therapy a few days later after we had some concerns. Unfortunately they did not work and our dog needed to be hospitalized (at a different ER in a different state). Our cardiologist and normal vet strongly believed this was a survivable crisis, but the ER disagreed and kept recommending euthanasia as there was no hope. We kept our dog hospitalized for IV fluid therapy for two nights, hoping to stabilize our dog to have some positive last moments at home before our vet would make a housecall for end-of-life services. We did not want them to pass in the hospital if at all possible. The ER vets kept stressing the hopelessness of the situation and imminent death due to the renal values not declining fast enough for them. Our vet and cardiologist both still had faith, noting the IV therapy was conservative due to cardiac concerns.
We brought our dog home and coordinated end of life plans with our vet. This included two blood tests, in case they somehow survived, to see if they stabilized at all. We all (vets and owners) wanted to see some accurate third party labs done, as we did not want to make an end-of-life decision based on faulty readings or margins of error. [The renal values exceeded the machine's readability, so were computed with a dilution factor.] I requested to leave the ER with a kit to administer subcutaneous fluids, so our dog would not dehydrate. After coming home, our dog was much less stressed and interested in eating and drinking again. I administered subcutaneous shots as directed, and coordinated with our normal vet to increase/decrease as needed as the situation improved.
Our dog survived to both blood tests, which both showed continued renal improvement. Despite the declines being moderate overall, our cardio and normal vet expected them to drop significantly slower and are incredibly pleased and expect the numbers to continue to drop over the next few weeks. They both think our dog is somewhere between stages 2-3 of Chronic Kidney Disease and not end-of-life. Neither understand the rush of the ER to euthanize. We've slightly adjusted heart medication and have begun kidney treatment.
Our dog won't live forever and we know their time is limited. Through careful management of his disease by board certified specialists, he has no symptoms and should remain that way for 9-12 months when he will begin to have symptoms and we will make the quality-of-life decision.
In both ER trips, the criticalists stressed hopelessness and recommended euthanasia. Both times, days after bringing our dog home, they are running around the house, racing up stairs, and playing with other dogs in a park or on the beach. With medicine, our dog's quality of life is excellent and they are no way near euthanasia on any of the scales used in this sub.
I am still trying to wrap my head around this, and figure out how/when I can trust ER vets and when I should be second guessing them. Is this a cultural thing? Is this based on education or clinical experience? There was a tangible rush and pressure to euthanize a dog who is in a survivable crisis with a condition that can be successfully managed with long term care.
For the vets that want to know about numbers:
The normal baseline of Creat/Bun is 2.1/75 +- 15% over the past 2 years.The cardiologist measured 2.3/86 - the day of diarrhea.Five days later, the normal vet measured 6.9/140.Three days after that, the ER projected 12.8/170.Two days later the ER discharged with 7.6/180 (bun was projected, creat was readable).Two days later, our vet measured 5.4/128.Two days later, our vet measured 4.9/114.We have a renal recheck in 2 weeks.

submitted by Mindless_Friend8235 to AskVet [link] [comments]


2024.02.23 23:20 Ok_Ability_479 Home care tips for canine renal failure

Canine 11.5 years Yorkie Mix 13lbs Late Stage Mitral Valve Disease USA
Our dog has late stage mitral valve disease. They have been on cardiac therapy drugs for 4 years. They were hospitalized in December for a first episode of CHF; in January we realized the cause was developing a tolerance to furosemide (kept increasing doses) and switched to torsemide. BUN and Creat were high but normal for them at the 10 day cardio checkup (86, 2.3) . On the 11th day they started showing signs of gastroenteritis (shaking, diminished appetite) that did not clear up. Normal vet and cardiologist both thought it was GI. On the 15th day, we brought the pup in for bloodwork and the vet was convinced it was GI. I was not. Test results came back and skyrocketed - BUN is at 150, Creat is 7.
Normal vet does not want to handle primary treatment, as everything they would do is contraindicated for the cardiac treatment. They called into cardio and had us follow up.
Cardiologist (board certified) thanked vet and confirmed they made the right call in stepping back for all the right reasons. Both feel IV fluids to flush out the system are extremely likely to trigger CHF. Both think there was probably a slight GI issue that snowballed into renal failure due to a mix of diuretics and dehyrdation. Cardio had us suspend diuretics and blood pressure meds, but keep pimobenden, send us to the normal vet for a subcutaneous fluid injection. We're to encourage hydration and eating, hoping the lack of meds and moderate hydration will help him reset. If there are any signs of breathing issues, we are to slowly introduce torsemide. If there are any signs that critical care is needed, we are to rush to emergency.
Are there any hyrdation tips people have here? Are there any conditions or tests we should ensure our care team explores? Our normal vet just sent out for thyroid tests.
We know we don't have much more time with our little guy, but he has had an EXCELLENT quality of life throughout the past few months and just had a great cardio checkup. Developing a furosemide tolerance was unfortunate; switching to torsemide gave us 10 amazing days of his best health since this summer - and really made us think he would last through the year.
submitted by Ok_Ability_479 to AskVet [link] [comments]


2024.02.08 19:54 Mindless_Friend8235 Is furosemide resistance known to be permanent?

Species: Canine Age: 11
We are seeing our cardiologist next week for a recheck, but I have a question until then-
After 3 months of Cardiologist/ER visits and declining health, we are finally pretty certain the underlying cause of everything is that our dog had developed a resistance to Furosemide. He has since switched to Torsemide and is doing exceptionally well now.
I have not been able to find out the following: is Furosemide resistance in dogs known to permanent or temporary (or not studied at all)? With human drugs, resistance is sometimes temporary and drugs are sometimes used in cycles to maintain efficacy. I can't find any information on canines regarding this.
Thank you!
submitted by Mindless_Friend8235 to AskVet [link] [comments]


2024.01.20 04:56 Pigeonofthesea8 NT-ProBNP 2,875 ng/L > BNP > 2930 pg/mL on furosemide, worsening egfr

Hi,
My dad was recently diagnosed with heart failure. Only treatment so far has been furosemide. 40 mg, then 80mg, then 60mg, then IV furosomide in the ER and now 80 again.
These are different tests and measurements - has there been any improvement?
His GP has maxed out the furosemide and said the cardiologist has to take it from here. Follow up isn’t until Feb 2. Cardiologist’s office said he’d be “keeping a close eye on results”.
Just got the lab result, it’s Friday night. The description under it says this is an “urgent” result (vs “follow up with your doctor”).
Thoughts?
Edit: his SOB is the same as two weeks ago. Feet aren’t swollen anymore. BP is ok, weight is ok.
But it’s concerning that his kidney function is way worse than it was two weeks ago, the diuretic is maxed out and his heart seems not to be improving.
I took him to one ER last week, he had high troponin twice and they let him go without treating him. Second ER, gave him IV furosemide and said his heart failure needs to be better controlled by his GP and/or cardiologist.
Enlarged ventricle, leaky valves - can medication help with these? He is not a candidate for invasive surgery because of his age.
submitted by Pigeonofthesea8 to Heartfailure [link] [comments]


2023.12.10 05:58 tonyeltigre1 Hims spray, does it really work?

Does the hims minoxidil and furosemide spray actually work? I always see the results from pictures but it’s hard to actually gauge the effectiveness because the before and afters are always “short buzz cut vs. long hair” or it’s just styled way differently and the hairs are just now covering different spots
submitted by tonyeltigre1 to tressless [link] [comments]


2023.08.26 15:32 Informal-Ad4197 Fluid challenge test vs furosemide stess test??

Is there any difference between the two in diagnosis ?
submitted by Informal-Ad4197 to Residency [link] [comments]


2023.07.27 16:42 AndreMauricePicard Follow-up: Pulmonary Oedema, treated as Anaphylaxis.

Full background: 77-year-old patient. Chagas, benign tumor on dorsam column, diabetes, high blood pressure, periohal arterial disease and chronic constipation. Glaucoma. Also renal insufficiency (found it after my transport)
In treatment with: Lactulon SOS, AAs 100mg/D, valsartan 160/12h, bisprolol 2.5/D, atorvastatin 20mg/A, clonazepam 2mg, metformin 500/12, , cilostazol 100mg/D and newly added furosemide 40mg/D
After this episode already shared She was hospitalized for 7 days. angiography was performed without lesions and echocardiogram FEY 60% AO 30 LV 53 S Y PP10 mild IAO concentric LVH. She was then diagnosed with renal insuficciency and furosemide was added a 40mg/day. Also she was instructed to reduce it to 20mg if planning to walk outside home. 2 week ago come to our base, to thank us, and gift us with a cake :)
But the monday she called due a new episode of dyspnea associated with high blood pressure. (190/100). Previos Saturday and Sunday BP levels were higher, and also increasing orthopnea. Both lungs with crackles in base, and Godet edema. She only took 20mg of furosemide that day. In the EKG RBBB + Left anterior fascicular block. I just pushed 40mg of furosemide IM. Left in observation for 3 hours in our small walk-in center. Checked her again and discharged with 140/90, without crackles in both lungs.
Yesterday she was added HCTZ 12.5 in the office by their new cardiologist. I understand that also 2mg of drospirenona would be added the next week. She didn't have an appointment until the 8/21... She won't make it alive to that date, so we moved earth and sky to get a appointment yesterday. I hope that we are on the right path.
I wanted to share it because it's a very tricky and interesting case. Lots of comorbilities including Chagas Disease perhaps not sot popular for northern hemisphere. It's endemic in my country and it causes lots of electrophysiological alterations in the heart.
submitted by AndreMauricePicard to ems [link] [comments]


2023.07.20 02:09 Awaythrowabcdefg123 Dosing schedule - CHF

Hi,
My dog has CHF and is being managed with pimobendan and furosemide at the moment. He recently had an episode where he was hospitalized for two nights to get the fluids in his lungs down and his breathing comfortable again. Obviously during his ER stint, his kidney values had been elevated as priority was his breathing.
Upon discharge, we were instructed to increase his furosemide dosage (.4mL of 25mg/mL suspension, previously from .3mL) with the frequency (3x a day) kept the same. We were told to get his lab work redone to check on his kidneys. Unfortunately his kidneys were even further elevated so our cardiologist told us to lower his furosemide to .3mL 3x a day. We were to recheck 2 weeks later.
We did another recheck and although his kidney values have decreased, not significantly enough to her liking. Her next instructions were to maintain the .3mL dose but to decrease the frequency to 2x a day and to be very on top of his breath counts so that we can stay on top of adjusting his medication if needed.
I am very very good at checking his breath count and keeping him calm. I am not concerned about this aspect but I am concerned that moving back to 2x a day would let too much fluids accumulate.
My question is: is there a difference in doing .2mL 3x a day vs .3mL 2x a day? In a 24 hour period, it’s still .6mL total. I am mostly curious about the difference in terms of keeping fluids out of his lungs and if/how it will affect his kidneys (positive/negatives of the dose/frequency).
Thank you all very much! Sorry for the typos or bad grammar, I am stressed and trying to get this all out on my phone.
submitted by Awaythrowabcdefg123 to AskVet [link] [comments]


2023.05.30 03:04 Bubzoluck [22 min read] Differences that Divide Us - The role of Racial and Sex based Medicine

[22 min read] Differences that Divide Us - The role of Racial and Sex based Medicine
Hello and welcome back to SAR! First off, I apologize for the hiatus in blog posts but had some things pop up and now I am clear! Alright off to the good stuff: For most things in life there are few reasons why one person of a particular sex or race would be more well suited to a particular job than another person of a different sex or race. Afterall, the quality of a cup of coffee would be just the same from a Black female barista with 10 years of experience as an Asian male barista with 10 years of experience. But medicine is a bit different; we do see differences because of sex or race that are important to understand, acknowledge, and factor into the diagnosis. Obviously a male isn’t going to have pregnancy on the differential diagnosis and prostate cancer isn’t a factor for female patients. The differences in Pharmacokinetics and Pharmacodynamics of a drug, a disease, or treatment can vary wildly between the sexes or between races. So today I want to look at the differences that we are only now starting to realize and the emerging role of Pharmacogenomics as the next horizon for medicine. So the big question is: you got something big in your genes or are you just happy to see me? :P
Disclaimer: this post is not designed to be medical advice. It is merely a look at the chemistry of medications and their general effect on the body. Each person responds differently to therapy. Please talk to your doctor about starting, stopping, or changing medical treatment.

Pharmaco—what?


https://preview.redd.it/m9y4cbtp9v2b1.png?width=747&format=png&auto=webp&s=1b116d1a0742dc8cc6bf458e684339fe3c2c34e6
Because I am a pharmacist I want to center our discussion on the drug choices and attributes influenced by sex and race but in order to do that we have to lay a foundation. The processes that move drugs from a pill into your body are broadly referred to as ADME but there is a hidden L step that is just as important to talk about as well. The lifecycle of a drug, LADME, are the five major processes that affect a drug inside the body. Let’s look:
  1. Liberation - When you swallow a tablet, the pill as a whole isn’t magically absorbed through the intestinal wall, it has to break down and liberate the drug from the dosage form. Liberation is the process of how the vehicle (what the drug is administered as) is broken down so the drug is free floating inside the body. This is also where we can see differences in timing such as extended release or immediate release products. It also governs other forms too like tablets you can chew or patches you apply onto the skin.
  2. Absorption - Now that the drug has left the tablet, it needs to move from the GI tract space into the body proper. The mucous membranes inside the intestine have a HUGE surface area allowing for many substances to be absorbed quickly and efficiently. How well a drug is absorbed plays a major factor in how well the drug’s action is. What if you're administering an oral (PO) antibiotic but the patient has diarrhea and they move the drug too quickly through the intestines? Can we be sure it was all absorbed? This is why we have alternative administration pathways like intramuscularly (IM), subcutaneous (SubQ), intravenous (IV), rectally (PR), vaginally (PV), optically (OU), and more. Each gets the drug inside the bloodstream where it can then get to the place it needs to go.
  3. Distribution - Speaking of getting where it needs to go, we have distribution. Once the drug is absorbed and dumped into the bloodstream, it needs to go to the place where the receptor, channel, or structure is for it to have action. Some places are easier to get to like highly vascularized (lots of blood vessels) areas like skin, the liver, and kidney while others are a bit harder such as the heart tissue, lungs, and brain.
  • “How does the drug know where to go?” It doesn’t! It will go everywhere in the body but that doesn’t mean that it will have action there. One good example is with Carbidopa, a dopamine receptor agonist used for Parkinson’s (oh look a post!). When a person take’s Carbidopa orally, it's absorbed into the blood and starts to distribute throughout the body generally. We want it to go to the brain to alleviate Parkinson's symptoms but it can also activate dopamine receptors in the periphery where it causes dizziness and constipation (I highly recommend reading the post if you want to learn how).
  1. Metabolism - Eventually the drug has to leave the body and metabolism is the first step in that process. Metabolism has two phases: phase 1 is responsible for deactivating the drug by modifying the structure of the drug in a way where it cannot fit inside the receptor anymore. Phase 2 takes the deactivated drug and makes it very water soluble so that it can leave the body extremely easily. The rate of metabolism is dependent on many different factors and is highly specific to each person which is why we do large pharmacokinetic studies in drugs before they are ready to be on the market. Failure to understand how a drug is metabolized can lead to toxicities from drug accumulation OR give too little a dose because the drug is metabolized so quickly.

https://preview.redd.it/5f8b8yxq9v2b1.png?width=490&format=png&auto=webp&s=64cd2ed43f824a34992bd51a7ed6ff322f4c1f70
5. Elimination - The last step in the drug lifecycle is elimination or how it physically gets out of the body. The majority of drugs leave via urine of which the kidney is responsible for that process. Having a working kidney is key for correctly dosing a drug because an underworking kidney may not eliminate the metabolized drug fast enough causing it to accumulate. There are other pathways too; fecal excretion (through biliary elimination) is another major route but some drugs can be eliminated via the lungs (such as alcohol, which is why it can be detected in a breathalyzer), through breast milk (which is why understanding drugs in pregnancy is SUPER important), sweat, saliva, and sebum.
Obviously there are major differences in LADME between males and females—after all it's hard to insert a drug vaginally in a male. But now that we have a general idea of what the drug is going to be doing, let’s dive into each section and talk about the sexual and racial differences we see at each step.

Liberation—”Liberty, equality, fraternity, or death; - the last, much the easiest to bestow, O Guillotine!”

When we think of liberation I want you to think of two things: getting the drug out of the formulation (such as the tablet or capsule breaking down in the stomach) and where that breakdown happens. These two factors are hugely important when we think about how the drug will eventually get absorbed—after all if you can’t liberate the drug correctly then there is no chance that it will be absorbed and then be utilized by the body. First let's talk about formulations:

https://preview.redd.it/1i6ih37u9v2b1.png?width=722&format=png&auto=webp&s=f86e20c6a57e892093cc05f809239e5d32dd5d75
  • In your daily life you’ve probably come across different formulations of drugs. Here we are going to look at the most basic of them: Immediate Release (IR), Delayed Release (SR), and Controlled Release (CR) also known as Extended Release (ER). The main differences between these different forms is how quickly the tablet moves from a solid lump sitting in your stomach to dissolved particles. The slower it releases then the slower the drug dissolves into your stomach and the slower it will eventually get absorbed. Initially all drugs were formulated as Immediate Release because we had little understanding of the utility of longer dosing formulations as well as we didn’t have the technology to do it. There are a whole bunch of different types of Extended Release types each with different uses and drawbacks and choosing which is best for your drug is extremely important for deciding what works best. At the end of this section is a diagram that shows all the different kinds of formulations.

https://preview.redd.it/87wzqtfv9v2b1.png?width=534&format=png&auto=webp&s=5823e621318faf23a995ebe62b305184ed433e20
  • But for now I want us to focus on the graph of drug liberation curves. The graph is divided into three zones with two very important barrier points: the Minimum Effective Level (MEL, aka MEC) and the Minimum Toxic Level (MTL aka MTC). Essentially if the curve of the line, representing the concentration of the drug in the body, is below the Minimum Effective Level then there isn’t enough drug to exert its action and we have Subtherapeutic levels in the body. Over time, the tablet dissolves more and more and the concentration continues to rise more and more and we pass the MEL into the Therapeutic Window where we see the action of the drug. In general we can say the higher you are in the Therapeutic Window, the greater the therapeutic effect there is or in other terms, the higher the dose the bigger the effect. Finally if you go above the Therapeutic Window you pass through the Minimum Toxic Level and enter into drug toxicity levels. Now, toxicity is a bit of a harsh word because this doesn’t mean we are going to see death but rather side effects due to too great of an effect of the drug. For example, say you are taking a drug that lowers blood pressure but due to changes in the tablet liberation the concentration rises above the MTL and your blood pressure drops a little too much and you get dizzy.

https://preview.redd.it/xpwwknrw9v2b1.png?width=792&format=png&auto=webp&s=b9d650e79ac21e385aa2be2dcf89865c332818cf
  • In the first graph we can see how drug design impacts the speed of liberation. Let’s say that we have 100mg of a drug that we are trying to put in the body. Using an Immediate Release formulation would result in a much quicker liberation and thus absorption into the body but we can see that it peaks very quickly and then drops off very quickly. So you may only get a few hours of usefulness out of the drug. Compare this to the Controlled Release system which peaks much slower but also declines much slower too, remaining much more Therapeutic for a longer period of time. We can see this in Adderall used for ADHD—most people will take an Extended Release (ER) formulation in the morning so that they get many hours of sustained therapeutic benefit while they are at school or at work. You can see one method of how the beads inside the Adderall capsule are made—called Pelletization. Essentially an inert core is layered with different chemicals/drugs to build an “Onion” of layers [insert Shrek reference].
    • So wouldn’t extended release always be better because we avoid the toxic levels of a drug? Not necessarily. To give an example of one of my patients, this person was a 911 operator who would take their Adderall XR every morning at 8:30am and work from 9am to 6pm every day. For them, their Adderall would start to wear off at 4pm, so they would get 7 hours of benefit. But what abouts the last two hours of the work day? They can’t be distracted in their job else it costs lives and taking another Adderall XR would mean they are wired until 11pm. No good. This is where the utility of IR formulations come in—this person can take an IR dose at 4pm when the Extended Release starts to wear off and boost their levels back into the therapeutic range and get 3 or 4 hours of benefit but have it be gone by the time they go to bed.

https://preview.redd.it/cfruoc1y9v2b1.png?width=777&format=png&auto=webp&s=77c85e5cb1ffbbc95fe5c461fa06d412750a4d8b

  • So hopefully you can see the utility of choosing different release systems now, but what about the second point: liberating in the right place in the body. Well some drugs are more effective if they are absorbed later in the digestive tract where it is less acidic versus the stomach. So some drugs may have better absorption if we can release them further towards the intestines than immediately dumping them into the stomach for absorption. This is where the utility of Delayed Release (DR) systems comes in. Drugs that are considered Acid Labile or sensitive to acid else they degrade are preserved better if they can liberate from the tablet in a less acidic environment. A great example of this is Omeprazole (Prilosec) which is used for decreasing the production of stomach acid to treat acid reflux or GERD—problem is that Omeprazole itself is very Acid Labile and if it enters the stomach unprotected then it degrades fairly quickly. This leads to the use of Omeprazole DR formulations where it is coated in substances that resist acid breakdown like Shellac or Sodium Alginate, thus allowing for the Omeprazole to be liberated in the small intestine where it is more likely to be absorbed.

https://preview.redd.it/5hnd2l6z9v2b1.png?width=546&format=png&auto=webp&s=22bf98592421616b1d1ceb84ee6fef5eb2518d3d
  • This is all well and good but how does this relate to sex and race? Well one of the major differences between males and females is that females have a more acidic stomach than males making their stomach environment much more acidic. In addition the Gastric Emptying Time, or how long it takes for substances to move from the stomach into the small intestine for absorption, is significantly longer in females. These two factors mean that females taking a drug that is Acid Labile are more susceptible to degradation in a female than in a male. This means the utility of an Enteric Coated drug which would resist stomach acid would be much more beneficial in a female than in a male. Let’s look at a specific example: the drug Carbidopa is used in Parkison’s to treat the tremors associated with the disease. In younger females, the peak blood concentration for Carbidopa is 22 minutes later than males of the same age. As a female ages and goes through menopause that time to peak becomes more and more similar to males meaning not only are we seeing variability in sex but also in age.
    • Another example is looking at the effect of a drug's natural acidity with the relative acidity of that person. Ketorolac (Ketorol) is a non-opioid pain medication used for moderate-severe pain in people where an opiate may not be preferred. The problem with Ketorolac is that it is extremely acidic naturally and it can cause ulceration of the stomach lining if someone has a very acidic stomach environment like a diet filled with acidic food. What we find is that males can have a Ketorolac dose 36% times higher than females because their stomachs are naturally less acidic meaning that they can handle a more acidic drug without the negative side effects like acid reflux or ulceration.
    • On a racial standpoint we see similar outcomes. It is reported that individuals of Asian descent have a lower acid output compared to Occidental patients. Part of this can be related to the relative smaller body habitus (weight and height) in the Asian population but there is also a decreased expression of acid-producing tissues in the Asian population than other races. When quantified it appears that Asians have about 60% the acid secretion of Caucasians which is a clinically significant difference when considering drugs that need a more basic environment. For example, Levothyroxine (Synthroid) is taken one hour before breakfast because we want the least acidic environment possible, which happens when the body has no food in it. What we find is that Asian populations need up to 55% smaller doses of Levothyroxine compared to non-Asians. Kinda interesting eh?

Is that a polymorphism in your pocket?

Originally I was going to look at each part of LADME individually but kept running into a problem when trying to separate the drug processes into silos. While Liberation is distinct from the rest of the process, ADME cannot really be separated into its components in a way where I can tell the story efficiently. As such we will focus on the poster drugs that are significantly affected by race and sex and then talk about the larger implications in therapeutic development. Now clearly there are drugs that are used in one sex over another, for instance you aren’t going to find Atosiban used to delay labor in a male or Sildenafil (Viagra) for erectile dysfunction in a female. Now that being said they do have other uses but you get the point—so if I talk about a drug please know that I may be talking about a specific indication as well. So with that in mind, let’s jump in!

https://preview.redd.it/t743qrdnav2b1.png?width=415&format=png&auto=webp&s=ab664f0523de9b7ade071ad07840698074dc1715
https://preview.redd.it/hdrinkpxav2b1.png?width=743&format=png&auto=webp&s=cc11930d2c0922801d093b2976afdb2d15df2d78
BiDil finds a home among Black patients—Hypertension, or high blood pressure, is one of the most common conditions across all races and sexes and is usually referred to as the “Silent Killer” because, well, it doesn’t hurt. Unlike liver failure or an infection, you won’t really see any symptoms of high blood pressure but after a decade of not treating it people do develop critical end organ damage: heart failure, kidney damage, liver damage, etc. Imagine that your veins are like a garden hose; if you put your thumb over the end of the hose the velocity of the water coming out of the hose increases meaning that there is more force. So if you have higher blood pressure, you have higher force hitting your organs. So the medical community has developed countless ways of lowering blood pressure to help save our organs and we can group those medications into a couple categories.
  • For the majority of the population we follow a pretty tried and tested protocol of drugs: first up we would use Diuretics which physically decrease the amount of fluid that is in the blood vessel. In the hose analogy this is like if you had a leak halfway up the hose lowering the amount of water exiting the hose at the end. Now there are dozens of diuretics but most people are familiar with Furosemide (Lasix) and how it makes people urinate more (y’know, to get rid of the fluid). If someone needs another agent we turn to drugs like the Angiotensin Converting Enzyme inhibitors (ACEi) or Angiotensin Receptor Blockers (ARBs). The ACEs (like Lisinopril, Enalapril, or Benazepril) and ARBs (Valsartan, Olmesartan, etc.) work by inhibiting the ability for a protein, Angiotensin, from connecting with the blood vessel wall. Angiotensin’s main job is to make the blood vessel smaller which would increase blood pressure—these drugs inhibit the action of Angiotensin thus preventing it from raising blood pressure. And our final category are drugs acting on the heart: Calcium Channel Blockers or Beta Blockers. While generally more helpful in situations like heart failure than hypertension, these drugs slow down the heart’s ability to pump blood which then lowers the force that the blood is acting on the blood vessels and organs. In a way it's like turning the faucet on the garden hose letting out less water into the hose.
    • So to summarize, the majority of people will benefit most from a Diuretic (which lowers the amount of fluid in the blood vessel), an ACEi or ARB (which prevents the blood vessels from getting smaller), and/or a CCB or BB (which lower the output of the heart).

https://preview.redd.it/iqua3w32bv2b1.png?width=343&format=png&auto=webp&s=8aeed509a15f83057db180b80eaf8b70b983a16d
Hydralazine vs Isosorbide Mononitrate
  • Enter the Venous Dilators which work by directly expanding the blood vessel size. These drugs are normally used in situations where the blood vessel is obstructed, such as during a heart attack or stroke, due to a clot. Administering a Venous Dilator would expand the blood vessel allowing the blood to wiggle around the clot and relieve the symptoms of the heart attack or stroke. Two of these drugs are Hydralazine and Isosorbide Dinitrate which are used by all sexes and races to prevent the progression of a heart attack and stroke which have very good success. Both of these drugs are fairly old: Isosorbide Dinitrate was discovered in 1949 while Hydralazine was discovered in 1949 and showed fairly good efficacy for decades.
    • Enter two doctors, Jay Cohn and Peter Carson, who wanted to market a new combination drug Hydralazine/Isosorbide Dinitrate (BiDil) in 1989 for congestive heart failure. The FDA said sure, go do a trial and so the duo set out to prove that BiDil was a good option for the general population. They tested their combination in a trial called Vasodilator-Heart Failure Trial (V-HeFT) against the gold standard Enalapril (ACEi) and found that BiDil was…bad. Like really bad, in fact they had to stop the trial early because it would have been unethical to keep people on the BiDil rather than on the known treatment. So V-HeFT didn’t show that BiDil was a good option for the general population except among one subpopulation: Black patients. When you look at the use of Enalapril (and other ACEi) in Black patients we find that the efficacy is quite low. As it turns out, people of African descent have a lower response to drugs like ACEi and ARBs compared to non-Africans meaning that they are worse options for a Black person. So a patient that wasn’t responding well to a Diuretic and needed a second agent would get little help from an ACE/ARB drug. And at this point in time there were no CCB or BB!

https://preview.redd.it/99xtjp79av2b1.png?width=424&format=png&auto=webp&s=76359060ec8bca632878ccfa135bb45120889f60
https://preview.redd.it/t2aruc4aav2b1.png?width=800&format=png&auto=webp&s=c213b5411f28486e2c2be56b7a4a7829654009a1
  • So Cohn and Carson’s drug application for BiDil was rejected in 1997 because the statistical analysis in their multi-racial study was quite bad. On the recommendation of one of the FDA’s advisory committees they stratified the data on racial lines and discovered a significant difference in response among Africans vs non-Africans. They started a new trial and enrolled 1050 African men and women showing a 43% decrease in mortality and a 39% reduction in hospitalization against placebo. They reapplied for BiDil and in 2005 the FDA approved the first ever race-based drug. To this day if you go to BiDil’s prescribing page in a drug database it will include a specific race designation because it’s only approved for a specific race. Importantly too national organizations like the American College of Cardiology and American Heart Association endorse this race based recommendation for Black patients.
    • Now this is great that we have a recommendation for a group of people that is superior to the normal regiment but there are a few complicating factors to consider. Firstly the term ‘Black patient’ isn’t really scientific—how Black does a patient need to be in order to qualify for BiDil? What kind of Black as well: African, Latin American, Caribbean, etc? Likewise this means it has to be self-reportable but what about a light-skinned Black person that was adopted and didn’t know they had Black genes? It's all very…unscientific. Recently there has been push back against this explicit race-based recommendation since other effective drugs do exist (like the CCB and BB which were discovered in 2006, one year after BiDil). There was a new study in 2022 from UCSF that talked about the role of prescribing based on race but personally I think there are too many confounders (influencing factors) like socioeconomic status to accurately say BiDil should be done away with. BiDil was shown to be effective in the Black population but how it gets applied is another story.

https://preview.redd.it/qs817v27bv2b1.png?width=570&format=png&auto=webp&s=bfb725e4bac64a0b564ac3ac9de7151b68ce3c1b
https://preview.redd.it/w71a739dbv2b1.png?width=500&format=png&auto=webp&s=5fb3dd3701992dc410e32638283928e29df14859
Liver Enzyme Distribution affects Metabolism—Once a drug is in the body it needs to be deactivated and removed eventually. This process of deactivating a drug happens during Metabolism which primarily happens in the liver via the Cytochrome P450 Enzymes. These CYP enzymes are like little factories that take up a drug and make slight modifications that remove its ability to affect the body. Each CYP enzyme is best suited for certain drugs while some enzymes, like CYP3A4 and CYP2D6, are able to handle a higher percentage of drugs. You can see in the pie chart above that some enzymes are more important in metabolism than others.
  • That being said, the distribution of the CYP enzymes is not constant from one person to another. For example, in females they have a higher distribution of CYP3A4 than males which can be thought of them having more deactivation factories than males. This means if we were to give the same dose to a female and a male the female would metabolize the drug much faster and thus have a decreased effect. This is incredibly important because CYP3A4 accounts for 30% of all drugs including birth control, many psychiatric drugs, and chemotherapeutics meaning that females would need higher doses than males, in theory. The opposite is true for CYP2E1 which is higher in males than females and is a metabolizer of ethanol (minor) and caffeine (major) which means that higher doses of both would be needed to have the same effect male vs female. Neat eh? Like there are sex differences for CYP enzymes we are starting to discover racial differences in CYP enzymes: we have identified Polymorphisms or small genetic variability among the genes that encode the CYP enzymes. Truthfully this isn’t surprising, we know there is genetic variability in genes that affect hair or eye color, so it's not too surprising that the CYP enzymes are equally affected. What is interesting is that the racial differences in CYP enzymes can lead to wildly different enzyme activity levels that lead to clinically significant differences in drug response. Or in simpler terms, some races respond better to some drugs because they have different liver enzymes!

https://preview.redd.it/qtt2o87ebv2b1.png?width=460&format=png&auto=webp&s=0e15a6dc5f1319aea23ec1209a47db87ec78e31b
  • Let’s take a look at one drug, Amitriptyline (Elavil) used for depression and anxiety, and how Polymorphisms result in changes in response. Quickly let's take a look at the metabolism: we can see that Amitriptyline is metabolized by two enzymes, CYP2D6 and CYP2C19. If it is metabolized by 2D6 first then it converts into an inactive metabolite that is eventually removed from the body. However if it first goes through 2C19 then it is converted to an active metabolite, Nortriptyline which would extend the action of the drug than if it went through 2D6. But if it does go through 2C19 then it will be handled by 2D6 into an inactive metabolite (bottom right), so either way we need 2D6 to get rid of the drug.

https://preview.redd.it/d57gfgqfbv2b1.png?width=772&format=png&auto=webp&s=ff186745a84bc3cc0f651bb11ba961a56a0bfa48
  • So let’s look at what happens when we mess with the metabolism of Amitriptyline through 2D6. Well if someone is a 2D6 poor metabolizer then they would be unable to clear the drug quickly and so it would hang around in the body longer—so more anti-depression activity (and side effects). We find that up to 10% of Caucasians are poor 2D6 metabolizers meaning that they would have a better response to Amitriptyline than those who are normal metabolizers. Likewise we find that up to 51% of Asians are intermediate metabolizers which has led to an overall increased response of 74%! The flip side to this are the Ultrarapid metabolizers who would clear the drug extremely quickly through 2D6 thus leading to a decreased response to Amitriptyline. Up to 29% of Subsaharan Africans are found to be Ultrarapid metabolizers meaning that Amitriptyline (and other drugs going through 2D6) is the wrong option for them.

https://preview.redd.it/wbvc02bhbv2b1.png?width=616&format=png&auto=webp&s=64bef947b9a5d21babaa06216b57df76c5e8f39c
  • Looking at 2C19 we see a much different distribution among the races. Remember that 2C19 converts the drug into an active metabolite which would extend the activity of the drug—if you don’t go through 2C19 then you’d have a decreased response. So patients who are Oceanian have a whopping 89% chance to be an intermediate or worse metabolizer and so a much MUCH higher chance of decreased response to Amitriptyline. Compare this to Caucasian patients who have a 32% chance to have increased activity on 2C19 meaning a potential increased response to Amitriptyline.

https://preview.redd.it/ardo2ygibv2b1.png?width=579&format=png&auto=webp&s=f8d09c0ec32bd15dba84dace849c87e1db58e1b3
  • Now is it really as simple as this? No, I am glossing over some of the finer details but I wanted to show how racial differences are a major factor in how drugs affect the body. Imagine if you had a population that had an 89% chance to have a decreased effect on birth control? Or what if you were a carrier of the HLA-B*5701 gene which means you are horribly allergic to the anti-HIV medication Abacavir (like up to 20% of Indians)? This is where the next generation of medicine comes from and the Clinical Pharmacogenetics Implementation Consortium is aiming to have their CPIC genomic guidelines become standard practice. In fact I am seeing more and more patients getting their liver enzymes done so we can see what kind of response they would have, especially if they have failed multiple drugs for a condition. Take a look at the guidelines page and see how many drugs are incorporated into the recommendations.
Regardless, pharmacogenetics has major impacts on how we treat patients every day but also may be a factor in some of the clinical disasters that we see. Afterall, 53% of Africans have decreased metabolism through CYP3A4 which is the major metabolizer of Fentanyl which may be a contributing factor why Blacks face higher overdose rates. If you haven’t, consider getting a pharmacogenomic test (many insurances will pay for it now) and unlock some secrets of your own body! Cheers!
submitted by Bubzoluck to SAR_Med_Chem [link] [comments]


2023.05.28 17:44 pylori pylori's Physiology Bites - Kidney function, acute kidney injury, and acid-base disorders

Welcome!
This is a series I am going to be working on where I endeavour to cover various topics in physiology intermixed with clinical pearls to impart some knowledge that doctors of most specialties and grades will hopefully find useful when looking after acutely unwell patients. Join me as we dredge through the depths of anaesthetic exam revision to answer important questions like "why do CT ask for a pink cannula", "why frusemide is okay to give in AKI", "why is hypoxic drive a bunch of horse manure" and many more. Pick up some of this material and you'll be well on your way to becoming a pernickety anaesthetist, whether you like it or not!
Questions, comments, feedback, and suggestions are both encouraged and welcome.

Previous installments:

Kidney function, acute kidney injury, and acid-base disorders

Next stop along our systems review are the mighty kidneys. I won't talk to you about Lupus nephritis or renal tubular acidosis, however I will try my best to cover some more typical things you might encounter like acute kidney injury (AKI) and drug dosing in renal impairment while trying to avoid embarrassing myself as a non-renal doctor.

What do the kidneys do?

An obvious question, they allow us to get rid of waste substances in urine. They are so much more than that however, they:
  • Regulate electrolyte concentrations, water balance and plasma volume, plasma osmolality
  • Regulate red blood cell production
  • Regulate blood pressure via RAA system influencing vascular resistance
  • Maintain acid-base homeostasis
  • Control Vitamin D production
  • Produce glucose from proteins and triglycerides (gluconeogenesis)
We will focus on only a few of these in this post, but the kidney's multiple roles and complex biochemical signalling deserves as mention as it can make diagnosing and understanding disease states difficult. It can also make us forget what other consequences there might be for patients in these disease states.

How do we measure kidney function?

In some respects knowing the heart or the brain aren't working is easy. Low blood pressure and infection? Septic shock. Low blood pressure + STEMI? Cardiogenic shock. Unconsciounsess or coma? Well whatever it is, it ain't working. So what about the kidneys, well we have creatinine, right? WRONG.
Although the kidney has many functions as we noted before, the easiest methods to quantify function look at the obvious: waste production. Its function is the sum of filtration through all the glomeruli in the kidneys, the glomerular filtration rate (GFR). When a substance is freely filtered through the kidneys and is neither secreted nor reabsorbed (which occur in the tubules rather than the glomeruli), the rate at which that substance is removed or cleared from the plasma can be used to measure GFR (in mL/min).
This substance is inulin and not creatinine. Because inulin isn't naturally present in our bodies, it has to be infused and then its concentration and the rate of decay measured. This is impractical clinically, so creatinine was selected as a practical alternative. The correlation between serum creatinine and measured GFR was researched and various formulas like MDRD and CKD-EPI were developed to estimate GFR (eGFR). This is why labs report eGFR as opposed to GFR. (There are also other methods to determine GFR like radionuclide scintigraphy...)

What's the problem?

The estimation of the GFR relies on assumptions that are not without problems. This review covers the topic at length, however the main points are:
  • Creatinine is secreted, unlike inulin. As mentioned this occurs in the tubules, so changes in secretion will affect serum creatinine level despite a static filtration rate. As renal diseases progress, more and more creatinine is secreted, making serum concentrations less reflective of actual filtration.
  • To truly reflect instrinsic renal function creatinine has to be in a steady state with stable generation and serum concentration. Creatinine is produced as a waste product of protein breakdown mainly from muscles. Therefore anything affecting catabolism, muscle activity, dietary protein intake, can alter this steady state. Frail sarcopenic patients will have artificially low creatinines and may not get as significant of a rise as a young muscular person in AKI.
  • There has to be adequate delivery of creatinine to the glomeruli. The kidneys receive ~20% of the cardiac output, so the heart has to be pumping out effectively with healthy blood vessels, good volume and blood flow. A hypovolaemic patient with an MI may have a high creatinine despite working kidneys, they're just not being adequately perfused. Chronic diseases like hypertension, diabetes, heart failure, lead to upset of autoregulation of normal afferent (entering) arterioles, whereas ACE inhibitors and ARBs block AT-II from causing vasoconstriction of efferent (outgoing) arterioles, an imbalance can lead to renal impairment if perfusion isn't maintained, or improved blood flow and urine output if it is.
  • The studies from which eGFR formulas are derived were conducted in mostly European and North American populations with elderly, black and CKD patients being significantly underrepresented. They only measured GFR a few times a year. With increasingly older, frailer, sicker patients, leading more sedentary industrialized diets and lifestyles, will the accuracy of these formulas hold up with time?
  • eGFR correlates loosely with important indicators like proteinuria, fluid status, blood pressure, acidosis, anaemia, bone disease, iron deficiency, tubular function, etc. In the absence of those indicators, the elderly often have decreased GFR without increases in morbidity and mortality.
The takeaway is that creatinine and eGFR are tools developed from the assessment and monitoring of long term renal function. It is not designed for use in patients with acute fluctuations or those with zero kidney function (eg, anuric dialysis dependent).

What else we can monitor?

The example of the heart earlier was misleading. Blood pressure is influenced by many factors. Septic shock is actually a high cardiac output state with low systemic vascular resistance (SVR). Patients with heart failure can have normal blood pressures despite severe systolic dysfunction and poor exercise tolerance. Blood pressure is an easy surrogate marker because determining cardiac output and SVR is invasive and complex (of course we have focused echocardiography to help us these days).
A surrogate marker we can use for the kidneys is urine output (UO). After all the end product of glomerular filtration is the ultrafiltrate which will become the urine. If there is adequate urine output despite raised or increasing creatinine levels, we can be reasonably satisfied the kidneys are actually receiving enough blood flow to get rid of waste and perform its other functions.

Acute Kidney Injury

This leads us into one of the most commonly encountered entities in hospitalised patients: AKI. Let's look at the KDIGO criteria seen in the table below.
AKI Stage Serum creatinine criteria Urine output criteria
1 SeCr increase ≥26 umol/L <48hrs or SeCr increase ≥1.5 - 2x from baseline <0.5mL/kg/hr for ≥6hrs
2 SeCr increase ≥2-3x from baseline <0.5mL/kg/hr for ≥12hrs
3 SeCr increase ≥354 umol/L <48hrs or SeCr increase ≥3x from baseline or started on renal replacement therapy (any stage) <0.3mL/kg/hr for ≥24hrs or anuria for ≥12hrs
Note: UO <0.5mL/kg/hr is the definition of oliguria.
Definining by creatinine is a more practical screening test in most situations, allowing earlier diagnosis and intervention. UO can be monitored during the course of the day to identify patients who are borderline or not responding to treatment, may need re-evaluation of the cause, or escalation of care. This way a combination of the two can help offset the limitations of each method.
NICE guidance already exists on the diagnosis and management of AKI, most hospitals will have care bundles or even 'AKI nurses', so I'll run over a few important points.
  • Pre-renal - This only means the cause lies outside the kidneys, and in at least in the early stages there is no histological change in the kidneys. In many cases like sepsis, diarrhoea, haemorrhage, there can be a relative or absolute fluid deficit and IV fluids are generally indicated. However excessive fluids can result in interstitial oedema in the kidneys, reducing the glomerular pressure gradient and so also reducing filtration. Similarly in poor cardiac output states where there is venous congestion there is a problem with the outflow of blood from the kidneys, so this is not a cause to reflexively withhold diuretics.
  • Intrinsic - Here there are structural histological changes in the kidney, caused by many intrinsic renal diseases or nephrotoxic agents like aminoglycosides, vancomycin, NSAIDs, etc. If this is suspected, stopping the offending agent generally resolves AKI without needing a biopsy. Furosemide is not mentioned here as it is not inherently nephrotoxic. Acute tubular necrosis is often mentioned as a specific clinical entity, either due to nephrotoxic agents or sustained hypoperfusion from pre-renal causes. It is not a very helpful term since histological tubular damage has rarely been proven in studies, nor does it help with treatment.
  • Post-renal - Obstruction may be incomplete, acute on chronic, with a normal ultrasound, no oligo/anuria, and may be associated with other pathologies like a kidney stone with pyelonephritis or sepsis. Catheters can get blocked too so don't forget a bladder scan if anuric, and obstruction can rarely be external such as by tumours or abdominal compartment syndrome.

When do I refer to renal or ICU?

Local protocols aside, advice should be sought when the patient does not appear to be responding to medical management and there may be a need for renal replacement therapy (RRT). This is often in the form of intermittent haemodialysis (iHD) on renal wards, and continuous venovenous haemodiafiltration (CVVHDF) in ICU. There are small differences in mechanism, efficacy, and indications of the many forms of RRT, the details of which aren't important for most non specialists. Generally accepted indications for RRT include:
  • Symptomatic uraemia - Encephalopathy, neuropathy, pericarditis. Elevated urea on its own is not generally an indication.
  • Hyperkalaemia - Persistent hyperkalaemia (>6.5) despite insulin/dextrose. Severe hyperkalaemia (>8 ) with arrhythmias, requiring pacing or isoprenaline. This can occur even without anuria and should be escalated as it obviously can be life threatening.
  • Severe metabolic acidosis, pH <7.1 - This will depend upon the cause and patient's condition. Patients with DKA and pH <7 can almost always quickly be turned around with insulin and fluids. Severely septic patients may not be able to tolerate medical management long enough to improve without RRT.
  • Toxins or overdose - Some medications and toxins may be removed by RRT (eg, lithium, vancomycin), with specific type of RRT better for some drugs than others. This is uncommon and decisions will depend on the input from renal, clinical state of the patient, and advice from toxbase or national poisons service. A drug may not be removed by RRT but if it leads to another entity such as acidosis it may still warrant RRT.
  • Fluid overload or pulmonary oedema refractory to diuretics - If patient is anuric despite diuretics then it's more likely they'll end up requiring RRT. In contrast pulmonary oedema in decompensated heart failure with worsening renal function is not helped more by RRT than by adequate diuresis.
Absent from above include oligo/anuria or specific values of urea and creatinine. This doesn't exclude them as considerations, however the whole picture should be taken together to make decisions on an individualised basis. It might be that the patient improves despite a creatinine of 700, it might be they become acidotic and hyperkalaemic with a creatinine of 400. Even on the ICU we still don't know when the right time is to start RRT.
This is a reason why renal and ICU often advise the generic "monitor I/O" rather than taking over care. We do appreciate accurate monitoring is unrealistic on the wards, but we also don't have the ability to admit everyone when few will need a specific intervention like RRT. An adequate UO to aim for is above 0.5mL/kg/hr. As AKI resolves some patients enter a polyuric phase, this will resolve but watch that they don't become hypovolaemic in the process, it may require further fluids matching what is lost.

Renal vs ICU referral

This will depend on local arrangements and acuity. Refer to renal if:
  • Single organ kidney failure - Normotensive haemodynamically stable patients, not septic or comorbid with poor cardiac function. The principal reason haemodialysis is intermittent because fluid is more rapidly removed therefore borderline hypotensive patients may not tolerate large volumes of blood and fluid being rapidly withdrawn from their intravascular space. I have seen patients arrest from starting dialysis!
  • Unclear cause of AKI - ICU can offer RRT as a bridge, but the underlying cause has to be treated, if the cause is unclear or there is persistent renal dysfunction, this will require renal input. We refer for this from the ICU too.
  • Diagnosis requiring specialist treatment - Immunosuppressive therapy for vasculitis.
  • Renal transplant patients - Even with a clear cause and response to treatment, the precarious nature of immunosuppression, renal impairment and graft function mean these usually merit a call to transplant renal physicians.
Refer to ICU if:
  • Multiorgan failure - Borderline blood pressure, high oxygen requirements, fluctuating consciousness level, coagulopathy, these patients are unlikely to tolerate iHD, but more importantly it suggests they are critically ill and may need rapid escalation of care (if appropriate) beyond what renal can provide (intubation, vasopressors, etc).
  • No on-site dialysis service - In hours there may be arrangements to transfer to partnetertiary hospital particularly for complex patients. However hospitalised dialysis patients known to the renal team may require more urgent RRT than this allows. Some ICUs have the plumbing to offer dialysis (this will need a dialysis nurse however).
  • Patient in extremis - ICU may be able to offer more timely input in patients needing urgent intervention especially if prior to surgery. A patient with bowel perforation and severe AKI will usually be septic and in multiorgan failure anyway, but a 70 year old with obstructive pathology may benefit from being close to theatre to offer RRT while awaiting a nephrostomy (or exchange). If it's reversible and there is somebody willing to operate, I would even dialyse a patient with a DNACPR we wouldn't otherwise admit.

Specific considerations

  • AKI in heart failure
    • The heart-kidney interaction is complex and works both ways (see this review). Volume status and cardiac function needs to be carefully evaluated. Seeing CCF documented in the notes is meaningless. What does their most recent echo show? What did they present with? Stable HF with reasonable ventricular function and sepsis with no signs of overload can receive fluids. Acute cardiogenic pulmonary oedema with severe ventricular dysfunction probably has AKI rooted in the decompensation of heart failure (type 1 cardio-renal syndrome) and would benefit from diuresis.
    • Acute decompensated HF is usually a hypervolaemic state. Elevated right atrial pressures reduce the arteriovenous pressure gradient in the kidney leading to venous congestion, poor outflow. Inflow is also limited adding to the poor cardiac output so glomerular filtration is reduced, leading to a vicious cycle. Aggressive diuresis with furosemide reduces this congestion, improves glomerular pressure gradient and increasing filtration (as long as the patient does not become hypovolaemic). Furosemide's initial beneficial effects in venous congestion is preceded by its diuretic action and is thought to be due to it causing venodilation, reducing preload. The addition of acetazolamide may improve decongestion further.
    • Creatinine rising is not an indication to stop diuresis, it may in fact signify adequate decongestion with improved patient outcomes.
  • AKI in liver disease
    • Like in heart failure this is a complicated topic (see this recent review). AKI is very common, occuring in up to 50% of hospitalised patients with cirrhosis. While we hear things like hepatorenal syndrome thrown around, common things being common we have to look at all the usual causes we've discussed first (so don't just throw terlipressin at everyone!)
    • Pre-renal causes are most common: Discontinue nephrotoxic drugs. Look for and cover for infections and spontaneous bacterial peritonitis. Hypovolaemia from diuretics or GI bleeds, resuscitate with crystalloids and blood as needed until euvolaemic (careful to avoid overload). Albumin has been found to improve survival in patients with SBP and can be considered if worsening renal function despite resuscitation (or following paracetensis for large volume >5L ascites). Hypervolaemia from congestion (cirrhotic cardiomyopathy leading to right heart failure can benefit from diuretics, abdominal compartment syndrome from tense ascites should be drained).
    • Intrinsic leaves us with tubulointerstitial causes and hepatorenal syndrome (HRS). Low fractional excretion of sodium and urine microscopy can help confirm HRS which offers a grim prognosis. Terlipressin may improve renal function at the cost of significant pulmonary oedema so regular volume assessment and avoidance of overload is paramount. RRT would only expected to be offered if waiting, or under consideration, for liver transplantation. If not, palliation will be the most likely alternative course.
  • Drug dosing
    • I would avoid using the BNF in renal impairment. Many of its recommendations are different than common guidelines and frankly weird. Do talk to your pharmacist (also microbiologist where appropriate), they'll often refer to The Renal Drug Handbook which is a good resource and covers scenarios like RRT. Most drugs will be dosed based on creatinine clearance not eGFR so arm yourself with an app or calculator.
  • Sodium bicarbonate
    • Bicarbonate infusions offer temporary extra buffering capacity, mopping up excess hydrogen ions resulting in a higher pH. This is beneficial in hyperkalaemia as a higher pH favours potassium moving intracellularly (for this reason saline is more harmful and Hartmann's more beneficial in hyperkalaemia). It also has accepted roles in tricyclic antidepressant overdose with adverse ECG findings (QRS, QT prolongation), urinary alkalinization (in salicylate poisonining, poor evidence in rhabdomyolysis), and normal anion gap metabolic acidosis (there is high cloride to replace loss of bicarbonate, see later).
    • Its use outside these indications is contentious. There is no evidence of benefit in DKA over conventional fluids even if normal saline's tendancy for acidosis may slow resolution of the acidaemia in DKA. It may be actively harmful in lactic acidosis and respiratory failure as the increased pH shifts the O2Hb dissociation curve to the left, causing reduced oxygen offloading. It also results in net CO₂ production (HCO₃⁻ + H⁺ → H₂CO₃ → H₂O + CO₂) which will have to be blown off with excess minute ventilation.
    • So why do ICU and renal advise it or use it themselves even with a lack of solid indications? Well, essentially it's a temporising measure. Severe acidaemia contributes to myocardial dysfunction, arrhythmias, and catecholamine resistance. In the critically ill it can be useful as a delay while you insert lines or in the hope it will avoid the need for RRT. The BICAR-ICU trial did find it delays the need for RRT and may even possibly reduce the need. I'm not entirely sold on the latter, but it can be reasonable to try if there are positive indicators like good UO.
    • How? Usually available in concentrated (8.4% with 1000mmol/L of each ion) or dilute (1.26% with 150mmol/L) forms. Due to the high tonicity of the former, 1.26% is generally preferrable especially if you can or want to give larger volumes. 8.4% should be reserved for fluid restricted states and should be given slowly via a central line except in an emergency. Slow infusions help combat significant CO₂ rises and hypernatraemia (especially with 8.4%). Dosing is 1 mmol/kg which is 1mL/kg of 8.4% or 6-7mL/kg of 1.26%. For real simplicity most patients can take a 50mL vial of 8.4% or 500mL bag of 1.26%.
  • Iodinated contrast
    • The entity contrast induced nephropathy, better termed contrast associated acute kidney injury, is a contentious topic. There are many good reviews already on this topic.
    • The evidence is from old studies using high osmolality agents during PCI. Fluctuations in creatinine may not be indicative of actual renal function and may simply reflect the underlying illness requiring a scan rather than the contrast itself. Patients are not more likely to need long term RRT.
    • IV contrast with modern low osmolality agents isn't associated with AKI in patients who aren't and even those who are critically ill. There was no association in patients even with pre-existing AKI. Prophylaxis with intravenous saline nor sodium bicarbonate have been found to make a difference even in CKD patients with eGFR >30.
    • The tl;dr is unless you're in cath lab or IR suite bolusing large quantities of dye arterially it is probably irrelevant. The benefit of a quality contrast enhanced scan in diagnosing and treating the patient are likely to outweigh any miniscule risk. RCR guidelines mention appropriate consent and identification of patients at risk (eGFR <40) they do not exclude the use of contrast or require hydration, at any renal function. You are the doctor, it's up to you to discuss and determine need and benefit. (It's the radiographer's job to ask, don't @ them, but they shouldn't refuse either).

Acid-base disturbances

Now it would seem we are forced to consider the fundamental concept of what acid-base physiology even is. You might have heard about strong ion difference and become lost in confusion. You're not alone. Put simply, there are two competing theories that try to explain how pH changes occur in the body: the traditional model that uses the Henderson-Hasselbalch equation to mathematically explain pH with bicarbonate, and the Stewart model that uses the concept of strong ion difference to explain why changes in bicarbonate occur. The bottom line is that these are detailed explorations of physiology more useful for bed time reading than the bedside. For the interested details can be read elsewhere.
More practically, we can work through a blood gas in a systematic fashion to help decipher the type of acid-base disturbance. Start with pH → PO₂ (always check oxygenation) → PCO₂ (respiratory component) → HCO₃⁻ (metabolic component). I've reproduced this in a simple but limited table below for reference, but this is a more intuitive flowchart to work through.
pH PCO₂ HCO₃⁻ Disturbance
<7.35 >6 Acute respiratory acidosis
Chronic respiratory acidosis
↔ /↓ <22 Metabolic acidosis
>7.45 <4.5 Acute respiratory alkalosis
Chronic respiratory alkalosis
↔ /↑ >26 Metabolic alkalosis
Numbers indicate primary abnormalities, arrows indicate compensatory changes. Respiratory compensation by altering ventilation occurs quickly, while renal compensation by altering bicarbonate excretion is a much slower process.

Respiratory

With the topic being the kidney, I won't discuss respiratory acidosis here (see this earlier physiology bite). Acute respiratory alkalosis is due to hyperventilation blowing off CO₂. This can be due to obvious things like pain or anxiety, a compensation for hypoxaemia (eg, high altitude climbing), pregnancy (increased minute ventilation stimulated by progesterone), or salicylate poisoning (direct stimulation of respiratory centre).

Metabolic

Dipping back into some physiology, we can consider two concepts that can give us more information: base excess and anion gap. The purpose of these concepts is help narrow our differential diagnosis, rather than serve as pathophysiological explanations of illness.
  • Base excess (BE) - This idea comes from Danish physicians during the polio epidemic where patients often experienced chronic CO₂ retention. For a standardised numerical way of gauging the degree of disturbance Siggaard-Andersen proposed BE to represent the quantity of acid in a lab that needed to be added to a solution of blood to normalise it to a pH to 7.40 and PCO₂ of 5.3. Not because the plan was to literally add acid, but this way you could easily quantify the degree of disturbance. Rather than use this concept Americans appear obsessed with the more complicated Winter's formula instead. Most blood gas analysers will calculate BE for us, often reported as standardised base excess (SBE), with a normal range of +/- 3. A negative base excess is sometimes described as a base deficit, they're the same thing.
    • SBE <-3 - There is a metabolic acidosis, alone or as compensation for a respiratory alkalosis.
    • SBE >3 - There is a metabolic alkalosis, alone or as compensation for a respiratory acidosis.
    • Mild -4 to -9, moderate -10 to -14, and severe <-15 (same but positive values for alkalosis)
    • It is especially helpful with mixed disorders or causes. A lactate of 4 doesn't explain a BE of -12 alone, are there other contributors to the acidosis? A bicarb of 30 doesn't explain a BE of +10, what else can be causing alkalosis?
  • Anion gap (AG) - I have a more detailed reply here explaining anion gap. It is a theoretical number that exploits the body's need to maintain electroneutrality: we have a bunch of positively charged ions (cations) that are evenly matched with negatively charged ions (anions), and we measure some of these. When we have an excess of some anions that we don't measure like lactate this calculated number rises because one of the measured anions (bicarbonate) drops to compensate to maintain electroneutrality. Like BE, most blood gas analysers will calculate AG for you.
There are far too many causes and detailed physiology to discuss here exhaustively. If you want to read about the Cori cycle, Type A and B lactic acidosis, helpful mnemonics and more, head to this review or this section on Deranged Physiology.

Metabolic acidosis

Symptoms are non-specific, with the most obvious being hyperventilation for compensation. In severely acidotic states (pH <7) seek early ICU help. Awake patients will hyperventilate sometimes down to PCO₂ <2 which can dramatically increase work of breathing. Initiating invasive ventilation in this stage or patient fatigue can be very dangerous if hyperventilation isn't maintained, the acidosis can worsen and precipitate cardiac arrest. Hypotension from vasodilation and reduced cardiac contractility can occur, as well as arrhythmias, confusion, delirium, coma.
  • High anion gap metabolic acidosis - The presence of unmeasured anions including: lactate, ketones (diabetes, starvation, alcoholic), salicylates, formate (metabolite of methanol), oxalate and glycolate (metabolites of ethylene glycol), other toxins.
  • Normal anion gap metabolic acidosis - Losses of base (bicarbonate loss in GI tract via high ouput ileostomy or diarrhoea, renal loss via acetazolamide) or excess of acid (renal tubular acidosis, hyperchloraemia, adrenal insufficiency).
  • Pitfalls: Albumin is an unmeasured anion, so low albumin can mask a high anion gap. Albumin corrected formulas have been developed. Similarly excessively high unmeasured cations like magnesium, calcium, and even lithium, can also lower the gap.
Treatment is aimed at eliminating the underlying cause with specific therapies as required like insulin in DKA, fomepizole for ethylene glycol poisoning, folinic acid in methanol poisoning, etc.

Metabolic alkalosis

Despite metabolic acidosis being the usual focus, metabolic alkalosis is actually the more common abnormality of the two in hospitalised patients and is frequently seen as a mixed disorder (like as a response to prolonged CO2 retention as seen in mechanically ventilated patients). In severe states it can lead to delirium, seizures, obtundation, arrhythmias.
The 'opposite' of acidosis, here we see a gain of alkali or loss of acid, with impaired bicarbonate excretion required to maintain this (via chloride or potassium depletion, impaired renal function, or volume depletion).
  • Gain of alkali - Iatrogenic from bicarbonate infusions, citrate in transfused blood.
  • Loss of acid - From the kidneys via diuretic therapy, or mineralocorticoid excess, hypokalaemia. From the GI tract by vomiting especially with pyloric stenosis or obstruction as there is gastric acid loss (with chloride) only, laxative abuse diarrhoea.
Treating the underlying cause is important as always. Where there is low chloride and hypovolaemia, this usually responds well to fluid replacement with saline and potassium as required. Acetazolamide can be given if there is hypervolaemia although in practice this is rarely required unless continued diuresis with other diuretics is required. Alkalosis results in low ionised calcium that can cause paraesthesias, but as calcium is buffered by albumin this rarely requires treatment and resolves with correction of the alkalosis.

Conclusion

This is another large topic where there was plenty to talk about. I had to cut down the scope significantly as it rapidly spun out of control, however I thought the nuances deserved a detailed writeup. Nothing is ever absolute so don't take any of this as incontrovertible evidence of the incompetence of a hated colleague (or their brilliance)! It will hopefully have given you some ideas to think about and research further when you see patients with AKI yourself.
Until next time!
submitted by pylori to JuniorDoctorsUK [link] [comments]


2023.03.22 23:47 MLJ21 Furosemide vs Fluids

Just wanted an update on the age old conundrum on which treatment would be best if you had a patient that was fluid overloaded but has really low BP?
submitted by MLJ21 to JuniorDoctorsUK [link] [comments]


2023.02.10 13:12 hswapnil Disappointing Diuretic trials on NephJC

submitted by hswapnil to nephrology [link] [comments]


2023.02.06 15:58 KamKalantar Mortality Similar With Torsemide, Furosemide for Patients Hospitalized With Heart Failure

Mortality Similar With Torsemide, Furosemide for Patients Hospitalized With Heart Failure submitted by KamKalantar to u/KamKalantar [link] [comments]


2023.01.24 19:14 qwaszz2 Need a safer alternative to furosemide

My dog with heart, liver and kidney disease was prescribed furosemide because she was coughing a lot due to her heart condition and buildup of fluid in the lungs. Since she's been on it her coughing has gotten much better, but her appetite has been low/ being a picky eater, and her breath started to smell really bad. I believe that the furosemise might be causing damage to her kidneys. I'm hoping there is some other safer alternatives I can try that aren't as bad on her kidneys. I saw that there was another option called torsemide online but I'm not sure if it's any better for kidneys.
submitted by qwaszz2 to AskVet [link] [comments]


2023.01.24 18:51 anonymous-shad0w Mortality Similar With Torsemide, Furosemide for Patients Hospitalized With Heart Failure

submitted by anonymous-shad0w to IndustrialPharmacy [link] [comments]


2022.09.07 17:55 Minimum-Designer-305 Feeling better.

I was in the hospital last week undergoing an intravenous diureses because I was retaining so much fluid. When I left they put me on Furosemide 40 mg three times a day. I switched to the Torsemide I have because I felt like the Furosemide wasn't working. I have lost about 28 lbs of fluid since going to the hospital. I'm eating little to no salt, lota of fruits, veggies, grains. I could barely move a little over two weeks ago, but I'm feeling much better! My EF is at 40%.
submitted by Minimum-Designer-305 to Heartfailure [link] [comments]


2022.05.14 21:47 Nor_Wester Heart Failure Questions

I don't have links to vet reports. As stated, she has been in heart failure for almost 3 months. She has been taking Pimobendan 7 1/2 mg twice daily, Furosemide 120 mg twice daily, and Enalapril 10 mg twice daily. It did well at first but 4-5 days ago the furosemide seems to have quit working, and her abdomen is swollen with fluid. I was told to increase it to 120 mg which had no effect. The vet yesterday told me to keep her on the Furosemide and add a 50 mg tablet of Spironolactone once daily.
She got the 1st one at 9PM last night. She seems to have peed more, but I woke up to her dry heaving this morning, has no appetite except for treats and seems sleepier than usual. I've read that if taken with food it may relieve the nausea, but I don't know if I should with the dry heaving appetite loss and tiredness that it caused. Also, I read today that Spironolactone shouldn't be taken with Enalapril? And why would we keep her on the Furosemide when it wasn't helping at all with fluid loss? Wouldn't switching her to Torsemide or another loop diuretic be a better course?
eta the spironolactone is once daily not twice.
submitted by Nor_Wester to AskVet [link] [comments]


2022.04.30 17:33 GummyOblongata furosemide vs spironolactone

Hello, I am misunderstanding the difference between furosemide and spironolactone as treatments for CHF, here is my understanding:
I know furosemide and spironolactone are diuretics.
Furosemide is the number drug used to treat CHF, it is potassium losing so, pee out potassium, retain sodium and water.
Spironolactone is potassium sparing so, retain potassium, pee out sodium and water. Spironolactone directly blocks aldosterone. Without aldosterone being blocked, sodium and water would be retained and pee out potassium=increase BP=make things bad for individuals with CHF. This part makes sense to me.
However, what is furosemide directly blocking and how does it helping people with CHF if it retains sodium and water?
submitted by GummyOblongata to pharmacology [link] [comments]


2022.04.13 07:01 ije912 Gained 18lbs in 2 weeks. No one knows why.

In May 2021, I (23 yo F, 22 at the time) very suddenly gained 18lbs in 14 days. My eating habits didn't change. I was the same size for almost 9 years. I weigh myself everyday and saw the gain every single day. I was finally able to get in to the doctor and they gave me furosemide. I was given a 4 day supply and lost 10 of the 18lbs gained. After I ran out, I had to wait 3 days for a refill. In those 3 days, I gained 7 of the lost 10lbs back (15lbs above my normal weight.) I was continued on furosemide, gradually increasing the doses until the end of July. At that point I was still gaining and now 20lbs above my normal weight. At the end of July they switched me to torsemide which I'm still currently on. I've seen my rheumatologist, cardiologist, gynecologist, a nephrologist who flat out told me that he didn't know what was wrong with me, suggested I try to stop taking the diuretic following with "if 4 months from now you're 200lbs we'll know it isn't salt and something else is going on" 🥴, and a dietician since my rheumatologist suggested it could be a sudden drastic slowing of my metabolism that is causing the water retention. Got the metabolism checked and it's faster than a normal person. Every day I take the torsemide and will drop as much as 5lbs in 2 hours. By the next day, I'm back up to where I started. My normal weight is 140lbs and I've been sitting at 160, some days a little more for months now. Endocrinology refuses to see me because my thyroid is normal even though i'd like more hormones tested. Gynecology tested my testosterone, estrogen, and progesterone. All normal, but I'm on birth control so it could have swayed the numbers. Note: I was not on birth control when all of this started. I had started no new medications at the time this began. No changes to eating habits, in fact, when I saw that I was gaining, I reduced my eating in fear. Hepatology doesn't want to see me because my liver numbers are showing normal, however, non-alcoholic fatty cirrhosis of the liver runs in my family, and has killed 2 of my cousins, and almost killed my mom. She had a liver transplant in 2019. You'd think that'd be reason enough to see me but I guess not. As for my medical history, my biggest issue is mixed connective tissue disease, but I do also have gastroparesis, atrial flutters, and vestibular migraines. I'm just really tired of feeling this way. It took me 2 years to get diagnosed with mixed connective tissue disease and the only reason why was because I did my own research and asked my dermatologist to test me for lupus. But this? I can't find anything on this, which is why I'm reaching out here. I know it may sound kind of shallow but not only do I feel just a constant state of "meh" but it's really doing a number on my self-esteem. Like I said, I was the same size for almost 9 years. Literally most of my clothes I've had since I was 14/15. If you have ANY idea as to what might be going on, please let me know, because every doctor I see is at a loss, and so am I. Thanks in advance. Age: 23 Sex: Female Height: 5'0.5" Weight: 160lbs Race: black, white, native american Duration of complaint: 11 months Location (Geographic and on body): KS, USA. Entire body Any existing relevant medical issues (if any): Mixed connective tissue disease, gastroparesis, vestibular migraines, atrial flutters, ovarian cysts Current medications (if any): hydroxychloroquine, nortriptyline, torsemide, potassium cl, vitamin d2, cetirizine, montelukast, famotidine, estarylla, xolair injection. All daily aside from d2 (once a week) and xolair (every 28 days)
submitted by ije912 to AskDocs [link] [comments]


http://rodzice.org/